Alnylam Pharmaceuticals (ALNY)

Add to Watchlists Create an Alert
68.47 -1.20  -1.72% NASDAQ Sep 2, 8:00PM BATS Real time Currency in USD

Alnylam Pharmaceuticals Net Income (Quarterly):

-250.94M for June 30, 2014

View 4,000+ financial data types

View Full Chart

Alnylam Pharmaceuticals Net Income (Quarterly) Chart

Export Data
Save Image

Alnylam Pharmaceuticals Historical Net Income (Quarterly) Data

View and export this data going back to 2003. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 -44.07M
March 31, 2014 -250.94M
Dec. 31, 2013 -32.36M
Sept. 30, 2013 -29.69M
June 30, 2013 -18.17M
March 31, 2013 -9.013M
Dec. 31, 2012 -62.19M
Sept. 30, 2012 -19.50M
June 30, 2012 -12.96M
March 31, 2012 -11.37M
Dec. 31, 2011 -14.30M
Sept. 30, 2011 -13.24M
June 30, 2011 -13.82M
March 31, 2011 -16.28M
Dec. 31, 2010 -6.93M
Sept. 30, 2010 -9.63M
June 30, 2010 -14.63M
March 31, 2010 -12.32M
Dec. 31, 2009 -7.791M
Sept. 30, 2009 -9.208M
June 30, 2009 -22.70M
March 31, 2009 -7.889M
Dec. 31, 2008 -9.392M
   
Sept. 30, 2008 -2.858M
June 30, 2008 -12.76M
March 31, 2008 -1.239M
Dec. 31, 2007 1.662M
Sept. 30, 2007 -52.79M
June 30, 2007 -12.69M
March 31, 2007 -21.64M
Dec. 31, 2006 -8.438M
Sept. 30, 2006 -7.40M
June 30, 2006 -9.91M
March 31, 2006 -8.86M
Dec. 31, 2005 -14.49M
Sept. 30, 2005 -10.68M
June 30, 2005 -11.14M
March 31, 2005 -6.60M
Dec. 31, 2004 -5.70M
Sept. 30, 2004 -6.416M
June 30, 2004 -6.956M
March 31, 2004 -13.58M
Dec. 31, 2003 -6.258M
Sept. 30, 2003 -6.258M
June 30, 2003 -3.244M
March 31, 2003 -2.151M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Get data for
Advertisement

ALNY Net Income (Quarterly) Benchmarks

Companies
Arrowhead Research -13.94M
RXi Pharmaceuticals -2.284M
Incyte

ALNY Net Income (Quarterly) Range, Past 5 Years

Minimum -250.94M Mar 2014
Maximum -6.930M Dec 2010
Average -30.42M

ALNY Net Income (Quarterly) Excel Add-In Codes

  • Metric Code: net_income
  • Latest data point: =YCP("ALNY", "net_income")
  • Last 5 data points: =YCS("ALNY", "net_income", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.